The drugs that keep rheumatoid arthritis in check may one day help people stop drinking. A new Scripps Research study shows that an anti-inflammatory molecule, already approved by the U.S. Food and Drug Administration to ...
Jun 29, 2026
0
7
A target trial emulation found that same-day coadministration of the COVID-19 and influenza vaccines was not associated with a higher risk of serious or clinically meaningful adverse events compared with receiving only an ...
Jun 29, 2026
0
7
The environment experienced by young zebrafish influences both the shape and electrical activity of the neurons in the eye, which affects subsequent behavior.
Jun 28, 2026
0
7
A QIMR Berghofer study has revealed that short periods outdoors during hours of low sunlight can cause skin damage and contribute to skin cancer risk.
13 hours ago
0
7
Very preterm infants face up to a 50% higher risk of developmental challenges affecting movement, learning, language and behavior. Today, many of those challenges are not fully recognized until later in infancy or early childhood. ...
Jun 24, 2026
0
6
Canada recently approved lecanemab to treat early Alzheimer's disease, but the clinical benefits are modest, it carries a risk of serious adverse effects, and treatment is complex. An article in the Canadian Medical Association ...
Jun 29, 2026
0
6
Periodontal (gum) disease is one of the most prevalent diseases worldwide, caused by the bacterium Porphyromonas gingivalis (P. gingivalis). In Japan alone, approximately 80% of adults 30 and older are affected or considered ...
20 hours ago
0
6
A revolutionary scanning technique has revealed that lithium MRI is a powerful tool for studying how the drug interacts with the brain and could offer more personalized treatment for bipolar disorder.
Jun 29, 2026
0
6
Researchers at the Icahn School of Medicine at Mount Sinai and the Lieber Institute for Brain Development have identified substantial similarities in brain gene activity among people with eating disorders and obsessive-compulsive ...
Jun 29, 2026
0
6
A new study from the Knight Initiative for Brain Resilience researchers may help explain an enduring mystery about amyotrophic lateral sclerosis (ALS): why the disease kills off some of the brain and spinal cord's movement-controlling ...
Jun 25, 2026
0
6
